1081O ctDNA reduction and clinical efficacy of the darovasertib + crizotinib (daro + crizo) combination in metastatic uveal melanoma (MUM)
Work
Year: 2023
Type: article
Source: Annals of Oncology
Institutions Sarah Cannon, University of California, Los Angeles, Princess Margaret Cancer Centre, University Health Network, Northwell Health +9 more
Cites:
Cited by: 8
Related to: 10
FWCI: 4.839
Citation percentile (by year/subfield): 56.29
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: closed